160 related articles for article (PubMed ID: 23134989)
1. Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris.
Silverberg JI; Silverberg NB
J Drugs Dermatol; 2012 Oct; 11(10):1228-30. PubMed ID: 23134989
[TBL] [Abstract][Full Text] [Related]
2. Examining the efficacy and safety of squaric acid therapy for treatment of recalcitrant warts in children.
Pandey S; Wilmer EN; Morrell DS
Pediatr Dermatol; 2015; 32(1):85-90. PubMed ID: 25040421
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of topical 80% trichloroacetic acid with 35% trichloroacetic acid in the treatment of the common wart.
Pezeshkpoor F; Banihashemi M; Yazdanpanah MJ; Yousefzadeh H; Sharghi M; Hoseinzadeh H
J Drugs Dermatol; 2012 Nov; 11(11):e66-9. PubMed ID: 23135096
[TBL] [Abstract][Full Text] [Related]
4. Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts.
Lee AN; Mallory SB
J Am Acad Dermatol; 1999 Oct; 41(4):595-9. PubMed ID: 10495383
[TBL] [Abstract][Full Text] [Related]
5. Squaric acid immunotherapy for warts in children.
Silverberg NB; Lim JK; Paller AS; Mancini AJ
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):803-8. PubMed ID: 10775858
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Multiple-Resistant and/or Recurrent Cutaneous Warts With Squaric Acid Dibutylester: A Randomized, Double-blind, Vehicle-controlled Clinical Trial.
DallʼOglio F; Luca M; Barresi S; Micali G
Dermatitis; 2017; 28(5):308-312. PubMed ID: 28885314
[TBL] [Abstract][Full Text] [Related]
7. Use of squaric acid dibutylester (SADBE) for cutaneous warts in children.
Micali G; Nasca MR; Tedeschi A; Dall'Oglio F; Pulvirenti N
Pediatr Dermatol; 2000; 17(4):315-8. PubMed ID: 10990585
[TBL] [Abstract][Full Text] [Related]
8. Cantharidin is Superior to Trichloroacetic Acid for the Treatment of Non-mucosal Genital Warts: A Pilot Randomized Controlled Trial.
Recanati MA; Kramer KJ; Maggio JJ; Chao CR
Clin Exp Obstet Gynecol; 2018; 45(3):383-386. PubMed ID: 30078935
[TBL] [Abstract][Full Text] [Related]
9. Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester.
Park HJ; Choi YW; Kim SH; Shin MS; Lee SW; Oh MK; Choi HY
Clin Exp Dermatol; 2013 Oct; 38(7):775-81. PubMed ID: 23611147
[TBL] [Abstract][Full Text] [Related]
10. An open, comparative clinical study on the efficacy and safety of 10% trichloroacetic acid, 25% trichloroacetic acid and cryotherapy for verruca plana.
Cengiz FP; Emiroglu N
Cutan Ocul Toxicol; 2015; 34(2):144-8. PubMed ID: 24938453
[TBL] [Abstract][Full Text] [Related]
11. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
Dall'oglio F; Nasca MR; Musumeci ML; La Torre G; Ricciardi G; Potenza C; Micali G
J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of squaric acid dibutyl ester in treatment of recalcitrant warts in children.
Bagherani N
Dermatol Ther; 2015; 28(5):330. PubMed ID: 25817990
[No Abstract] [Full Text] [Related]
13. [Immunotherapy of multiple recurring warts. II. Reassessment of the use of squaric acid dibutylester (SADBE) (author's transl)].
Claudy AL; Roche H
Ann Dermatol Venereol; 1981; 108(10):765-7. PubMed ID: 7305218
[TBL] [Abstract][Full Text] [Related]
14. Adult and paediatric contact immunotherapy with squaric acid dibutylester (SADBE) for recurrent, multiple, resistant, mucocutaneous anogenital warts.
Dall' Oglio F; Nasca MR; D'Agata O; Micali G
Sex Transm Infect; 2002 Aug; 78(4):309-10. PubMed ID: 12181482
[No Abstract] [Full Text] [Related]
15. Contact immunotherapy with squaric acid dibutylester for warts [corrected].
Iijima S; Otsuka F
Dermatology; 1993; 187(2):115-8. PubMed ID: 8358098
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review.
Vakharia PP; Chopra R; Silverberg NB; Silverberg JI
Am J Clin Dermatol; 2018 Dec; 19(6):791-803. PubMed ID: 30097988
[TBL] [Abstract][Full Text] [Related]
17. Use of trichloroacetic acid for management of oral lesions caused by human papillomavirus.
Carmona Lorduy M; Harris Ricardo J; Hernández Arenas Y; Medina Carmona W
Gen Dent; 2018; 66(2):47-49. PubMed ID: 29513235
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cutaneous warts with squaric acid dibutylester: a decade of experience.
Micali G; Dall'Oglio F; Tedeschi A; Pulvirenti N; Nasca MR
Arch Dermatol; 2000 Apr; 136(4):557-8. PubMed ID: 10768664
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
Ajith C; Gupta S; Kanwar AJ
J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
[TBL] [Abstract][Full Text] [Related]
20. Cantharidin treatment for recalcitrant facial flat warts: a preliminary study.
Kartal Durmazlar SP; Atacan D; Eskioglu F
J Dermatolog Treat; 2009; 20(2):114-9. PubMed ID: 18821118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
